NCT02170662View on ClinicalTrials.gov

Topical Bimatoprost Effect on Androgen Dependent Hair Follicles

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Male Pattern Hair LossAndrogenetic Alopecia
Interventions
DRUG

Bimatoprost

Bimatoprost 0.03% ophthalmic solution as purchased from the manufacturer will be the active drug.

DRUG

Placebo

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER